Home Overview Press Room Blog Publications For Students about us
Search

About the States' Policies & Human Biotechnology


Individual states are filling the regulatory void created by the federal government’s failure to provide comprehensive legislation governing human biotechnologies. This is creating an often inconsistent policy patchwork.

California

State action is evident in a number of areas, including embryonic stem cell, cloning, egg retrieval, and assisted reproduction. More than a dozen states have laws banning reproductive cloning, about half of which also prohibit cloning for stem cell research. Dozens of similar bills are introduced in other states each year.

In response to President Bush’s restrictions on the federal funding of human embryonic stem cell research, several states initiated their own funded research programs. California led the way in 2004 with Proposition 71, which set aside $3 billion of public funds for stem cell research over ten years.



Sure Genomics wants to sell private genetic profiles for $2,500, but it’s really testing the FDAby Arielle Duhaime-RossThe VergeFebruary 9th, 2016From a regulatory standpoint, Sure Genomics is treading on thin ice. The FDA has warned other companies about similar practices.
A Single Blood Test For All Cancers? Illumina, Bill Gates And Jeff Bezos Launch Startup To Make It Happen by Matthew HerperForbesJanuary 10th, 2016The new startup is called GRAIL, because such a test would be a holy grail for cancer doctors. It already has $100 million in funding.
Whiteness and “Making a Murderer”: Manitowoc, the “One-Branch Family Tree” and the Sinister Race Science of “Degenerate Whites”by Kate TuttleSalonJanuary 7th, 2016The Avery clan’s reputation as "trouble" echoes myths planted by inane, racist eugenicists in the early 1900s.
Whatever Happened to Human Experimentation?by Carl ElliottHastings Center ReportJanuary 1st, 2016The choice to abandon the word “experiment” is emblematic of a larger movement beginning in the 1990s, in which many bioethics scholars moved from being critics of the research enterprise to being its champions.
The Chances Of Success For IVF Improve The More Times You Do It, Study Finds, But It Also Highlights The Gap In Accessibilityby Erin McKelle FischerBustleDecember 30th, 2015Multiple rounds of IVF require tens of thousands of dollars and months to years of treatment; success is often only for the privileged.
Genetic Testing May Be Coming to Your Officeby Rachel Emma SilvermanThe Wall Street JournalDecember 15th, 2015Health advocates raise concerns about privacy and the potential for illegal discrimination based on employees’ genetic information.
Putting a Price on Human Eggs Makes No Senseby Debora SparFortuneNovember 21st, 2015No one wants to deal with the ugly reality that egg donation is not donation at all, but a high price paid for a piece of one’s body.
California Judge Orders Frozen Embryos Destroyed[cites CGS Fellow Lisa Ikemoto]by Andy NewmanThe New York TimesNovember 19th, 2015A superior court judge in San Francisco ordered the thawing and destruction of a divorced couple's frozen embryos, enforcing the terms of the couple's pre-divorce agreement.
Forgotten Stories of the Eugenic Age #4, Part 3: The Blurry Boundaries of Eugenic Infanticideby Natalie OveyssiBiopolitical TimesOctober 29th, 2015The final entry of the three-part examination of Dr. Harry Haiselden, Baby John Bollinger, and the practice of eugenic infanticide explores the legacy of Haiselden’s career and its meaning for the rights of individuals with disabilities.
Making Indigenous Peoples Equal Partners in Gene Researchby Ed YongThe AtlanticOctober 23rd, 2015After leaving a partnership with NIH in 2003, the Akimel O’odham (Pima) tribe is retaining control of their bio samples and shaping the goals of a diabetes project with genomic researchers.
Displaying 1-10 of 413  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760